Response by Kazi et al to Letter Regarding Article, "Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy"

Affiliations

• ¹ Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Boston, MA (D.S.K., S.J.B., C.S., R.W.Y.).
• ² Division of Cardiology, Beth Israel Medical Center, Boston, MA(D.S.K., C.S., R.W.Y.).
• ³ Harvard Medical School, Boston, MA (D.S.K., C.S., R.W.Y.).
• ⁴ Columbia University Irving Medical Center, New York, NY(B.K.B., M.S.M.).
• ⁵ Saint Luke's Mid America Heart Institute, Kansas City, MO(J.A.S.).
• ⁶ University of Missouri-Kansas City(J.A.S., D.J.C., S.V.A., B.W.S.).
• ⁷ Lahey Hospital and Medical Center, Burlington, MA(S.J.B., S.V.A., B.W.S.).
• ⁸ Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).